| Detected | Trial | Change |
|---|---|---|
| 2026-08-05 | NCT06366750 A Study of Barzolvolimab in Patients With Prurigo Nodularis |
date change Primary completion moved earlier: 2026-06 -> 2026-03-17 |
| 2026-07-30 | NCT07256392 Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With… |
Trial sites expanded: 63 -> 96 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07266402 | A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo… | Chronic Inducible Urticaria | Recruiting |
| NCT06445023 | A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria | Chronic Spontaneous Urticaria | Active, Not Recruiting |
| NCT06455202 | A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) | Chronic Spontaneous Urticaria | Active, Not Recruiting |
| NCT07256392 | Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With… | Chronic Spontaneous Urticaria | Enrolling by Invitation |
| Phase 2 | |||
| NCT06366750 | A Study of Barzolvolimab in Patients With Prurigo Nodularis | Prurigo Nodularis | Active, Not Recruiting |
| NCT06727552 | A Study of Barzolvolimab in Patients With Atopic Dermatitis | Atopic Dermatitis | Active, Not Recruiting |
| Phase 1 | |||
| NCT07330778 | A Study of CDX-622 in Participants With Mild to Moderate Asthma | Mild to Moderate Asthma | Recruiting |